MA25509A1 - Composition destinee au traitement de l'hepatite c - Google Patents

Composition destinee au traitement de l'hepatite c

Info

Publication number
MA25509A1
MA25509A1 MA26657A MA26657A MA25509A1 MA 25509 A1 MA25509 A1 MA 25509A1 MA 26657 A MA26657 A MA 26657A MA 26657 A MA26657 A MA 26657A MA 25509 A1 MA25509 A1 MA 25509A1
Authority
MA
Morocco
Prior art keywords
hepatitis
treatment
composition
Prior art date
Application number
MA26657A
Other languages
English (en)
French (fr)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of MA25509A1 publication Critical patent/MA25509A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA26657A 2000-03-22 2002-05-28 Composition destinee au traitement de l'hepatite c MA25509A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c

Publications (1)

Publication Number Publication Date
MA25509A1 true MA25509A1 (fr) 2002-07-01

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26657A MA25509A1 (fr) 2000-03-22 2002-05-28 Composition destinee au traitement de l'hepatite c

Country Status (17)

Country Link
JP (1) JP2003527414A (de)
KR (1) KR20020087045A (de)
CN (1) CN1416347A (de)
AT (1) AT408719B (de)
AU (1) AU2001239000A1 (de)
BG (1) BG107088A (de)
BR (1) BR0107211A (de)
CA (1) CA2389173A1 (de)
EA (1) EA200200584A1 (de)
HR (1) HRP20020367A2 (de)
IL (1) IL149314A0 (de)
IS (1) IS6360A (de)
MA (1) MA25509A1 (de)
MX (1) MXPA02004993A (de)
NO (1) NO20022253L (de)
PL (1) PL365000A1 (de)
WO (1) WO2001070203A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (de) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternäre Chelidonin- und Alkaloidderivate, Verfahren zu deren Herstellung und deren Verwendung in der Herstellung von Arzneimitteln
EP2083825A4 (de) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Zusammensetzungen zur behandlung von hepatitis c und verfahren zur verwendung von zusammensetzungen zur behandlung von hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
EA200200584A1 (ru) 2003-06-26
IL149314A0 (en) 2002-11-10
BR0107211A (pt) 2004-01-06
BG107088A (en) 2003-05-30
WO2001070203A2 (de) 2001-09-27
JP2003527414A (ja) 2003-09-16
NO20022253D0 (no) 2002-05-10
AT408719B (de) 2002-02-25
CN1416347A (zh) 2003-05-07
HRP20020367A2 (en) 2004-02-29
NO20022253L (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
PL365000A1 (en) 2004-12-27
IS6360A (is) 2002-04-24
KR20020087045A (ko) 2002-11-21
ATA4812000A (de) 2001-07-15
WO2001070203A3 (de) 2002-09-06
AU2001239000A1 (en) 2001-10-03
CA2389173A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR20C1039I2 (fr) Derives de l'uk-2a
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
EP1346724A4 (de) Mittel zur behandlung von hepatitis c
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
MA26207A1 (fr) Compositions de traitement de l'eau.
MA25823A1 (fr) Compositions pour le traitement de l'eau.
EP1165110A4 (de) Antagoniste von hmg1 zur behandlung von entzündungskonditionen
ATE315938T1 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
EE200300307A (et) 1,5-bensotiasepiinid ja nende kasutamine antilipideemiliste vahenditena
DE69912223D1 (de) Methylmethacrylat-Zusammensetzung
EP1390029A4 (de) Phenylindole zur behandlung von hiv
PT1250321E (pt) Composicao de gliburida
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
EP1240552A4 (de) Wässrig entwickelbarer fotoresist
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
EE200200590A (et) Bradükardiaalsete toimeainete kasutamine hüpertroofiaga seotud müokardiaalsete haiguste ravimiseks ja uudsed ravimikombinatsioonid
EP1357940A4 (de) Hepatitis?b?virustherapie
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
EP1161255A4 (de) Verfahren und mittel zur behandlung erektiler dysfunktion
EP1156799A4 (de) Methoden zur behandlung der cole(chronisch obstruktive lungenerkrankung)